JP2009518312A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009518312A5 JP2009518312A5 JP2008543545A JP2008543545A JP2009518312A5 JP 2009518312 A5 JP2009518312 A5 JP 2009518312A5 JP 2008543545 A JP2008543545 A JP 2008543545A JP 2008543545 A JP2008543545 A JP 2008543545A JP 2009518312 A5 JP2009518312 A5 JP 2009518312A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- plant exudate
- plant
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000416 Exudates and Transudates Anatomy 0.000 claims 17
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 102000004169 proteins and genes Human genes 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 4
- 244000005700 microbiome Species 0.000 claims 4
- 210000000987 Immune System Anatomy 0.000 claims 3
- 108009000578 Oxidative Stress Proteins 0.000 claims 3
- 230000036542 oxidative stress Effects 0.000 claims 3
- 241000282472 Canis lupus familiaris Species 0.000 claims 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- 241000283086 Equidae Species 0.000 claims 2
- 241000282326 Felis catus Species 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000002503 metabolic Effects 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 239000003223 protective agent Substances 0.000 claims 2
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 1
- 206010047461 Viral infection Diseases 0.000 claims 1
- 208000001756 Virus Disease Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000002496 gastric Effects 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 230000003818 metabolic dysfunction Effects 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000017613 viral reproduction Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74177405P | 2005-12-02 | 2005-12-02 | |
| PCT/US2006/046320 WO2007065024A2 (en) | 2005-12-02 | 2006-12-04 | Composition and use of phyto-percolate for treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009518312A JP2009518312A (ja) | 2009-05-07 |
| JP2009518312A5 true JP2009518312A5 (de) | 2011-03-03 |
Family
ID=38092904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008543545A Pending JP2009518312A (ja) | 2005-12-02 | 2006-12-04 | 疾患を治療するための植物浸出物の組成物および使用 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1954800A4 (de) |
| JP (1) | JP2009518312A (de) |
| AU (1) | AU2006320264A1 (de) |
| CA (1) | CA2631773C (de) |
| WO (1) | WO2007065024A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110117122A1 (en) * | 2009-11-16 | 2011-05-19 | Tiffany Thomas | COMPOSITION AND METHOD FOR AFFECTING CYTOKINES AND NF-kB |
| US10166270B2 (en) | 2004-04-23 | 2019-01-01 | Zivo Bioscience, Inc. | Composition and method for affecting cytokines and NF-κB |
| US7807622B2 (en) | 2004-04-23 | 2010-10-05 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
| US8586053B2 (en) | 2005-09-21 | 2013-11-19 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
| MX2012009678A (es) | 2010-02-22 | 2013-06-03 | Health Enhancement Products Inc | Agentes y mecanismos para tratar la hipercolesterolemia. |
| US20160051526A1 (en) * | 2013-04-09 | 2016-02-25 | Cresset Biomolecular Discovery Ltd | The Local Treatment of Inflammatory Ophthalmic Disorders |
| WO2014201372A1 (en) | 2013-06-13 | 2014-12-18 | Health Enhancement Products, Inc. | Compounds and methods for affecting cytokines |
| ES2972377T3 (es) | 2015-02-16 | 2024-06-12 | Zivo Bioscience Inc | Composiciones antinflamatorias e inmunomoduladoras que comprenden Klebsormidium y usos de las mismas |
| CA3014897C (en) | 2016-02-16 | 2020-12-29 | Zivo Bioscience, Inc. | Nutritional support for animals via administration of an algal derived supplement |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001287382B9 (en) * | 2000-08-10 | 2006-10-26 | Ocean Nutrition Canada Limited | Chlorella preparations exhibiting immunomodulating properties |
| EP1750734A4 (de) * | 2004-04-23 | 2009-09-16 | Health Enhancement Products In | Verfahren zur herstellung und verwendung von fibrinolytischen enzymen zur behandlung von krankheiten |
-
2006
- 2006-12-04 WO PCT/US2006/046320 patent/WO2007065024A2/en active Application Filing
- 2006-12-04 EP EP06838974A patent/EP1954800A4/de not_active Withdrawn
- 2006-12-04 JP JP2008543545A patent/JP2009518312A/ja active Pending
- 2006-12-04 AU AU2006320264A patent/AU2006320264A1/en not_active Abandoned
- 2006-12-04 CA CA2631773A patent/CA2631773C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009518312A5 (de) | ||
| Vijay | Toll-like receptors in immunity and inflammatory diseases: Past, present, and future | |
| Hasday et al. | The role of fever in the infected host | |
| Wang et al. | Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice | |
| Steidler et al. | Therapeutic drug delivery by genetically modified Lactococcus lactis | |
| Tanno et al. | Invariant NKT cells promote skin wound healing by preventing a prolonged neutrophilic inflammatory response | |
| Jiang et al. | Acid-activated antimicrobial random copolymers: a mechanism-guided design of antimicrobial peptide mimics | |
| Cho et al. | Orientia tsutsugamushi induced endothelial cell activation via the NOD1-IL-32 pathway | |
| Chen et al. | The role of Th17 cells in inflammatory bowel disease and the research progress | |
| WO2008076915A3 (en) | Treatment of pigs with pcv2 antigen | |
| Kumar et al. | IL-22: an evolutionary missing-link authenticating the role of the immune system in tissue regeneration | |
| US20230048366A1 (en) | Combination therapy for treating or preventing cancer | |
| Umeda et al. | Signaling transduction analysis in gingival epithelial cells after infection with Aggregatibacter actinomycetemcomitans | |
| Dzopalić et al. | Function of innate lymphoid cells in the immune-related disorders | |
| Betancourt et al. | Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis | |
| GB2453491A (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof | |
| Takakura et al. | Influences of orally administered lactoferrin on IFN-γ and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells | |
| Okita et al. | Interleukin-22-induced antimicrobial phospholipase A2 group IIA mediates protective innate immunity of nonhematopoietic cells against Listeria monocytogenes | |
| Kelly et al. | Staphylococcus aureus-induced immunosuppression mediated by IL-10 and IL-27 facilitates nasal colonisation | |
| Puddu et al. | Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages | |
| Kobayashi et al. | The anti-atherosclerotic dipeptide, Trp-His, reduces intestinal inflammation through the blockade of L-type Ca2+ channels | |
| WO2007036735A3 (en) | Immunogenic agents againts burkholderia psudomallei and/or burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from burkholderia psuedomallei | |
| ATE532510T1 (de) | Aminosäure-phenoxy-ether, ihre herstellung und verwendungen | |
| Yang et al. | Saccharomyces boulardii administration can inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection | |
| Roth et al. | Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines |